Par Drugs & Chemicals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 19.97 | 30.67 | 29.14 |
| Operating Expense | 18.17 | 23.28 | 22.59 |
| Net Profit | 0.85 | 4.80 | 4.13 |
| Net Profit Margin | 4.26% | 15.65% | 14.17% |
| Earning Per Share | 0.69 | 3.90 | 3.36 |
| EBIDTA | 2.13 | 7.38 | 6.54 |
| Effective Tax Rate | 17.22% | 22.19% | 21.68% |
Particulars
Mar 2026
Revenue19.97
Operating Expense18.17
Net Profit0.85
Net Profit Margin4.26
Earning Per Share0.69
EBIDTA2.13
Effective Tax Rate17.22
